Jpmorgan Chase & Co »

Nervgen Pharma Ord shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Nervgen Pharma Ord (NGEN) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Nervgen Pharma Ord

Tip: Access up to 7 years of quarterly data

All positions including Nervgen Pharma Ord held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nervgen Pharma Ord by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $29k 15k 1.96
2026-03-31 $79k 14k 5.84

More positions owned by Jpmorgan Chase & Co

Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Microsoft Corp Common (MSFT)
Alphabet Common (GOOG)
Amazon Common (AMZN)
Broadcom Common (AVGO)
State Street Spdr S&p 500 Etf Fund (SPY)
Alphabet Common (GOOGL)
Micron Technology Common (MU)
Meta Platforms Common (META)
Advanced Micro Devices Common (AMD)
Lam Research Corp Common (LRCX)
Tesla Common (TSLA)
Vanguard S&p 500 Etf Fund (VOO)
Eli Lilly & Co Common (LLY)

View all positions for Jpmorgan Chase & Co

Top funds holding Nervgen Pharma Ord

Empery Asset Management
Rock Springs Capital Management
DAFNA Capital Management
Ghisallo Capital Management
Armistice Capital
LMR Partners
Marshall Wace
UBS Group
Stonepine Capital Management
Jane Street
Woodline Partners
PFG Investments
Susquehanna International
Bank of America Corporation
Royal Bank of Canada

View all funds holding Nervgen Pharma Ord